Literature DB >> 19041316

Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function.

Kyle C McKenna1, Kelly M Beatty, Rodolfo Vicetti Miguel, Richard A Bilonick.   

Abstract

We tested whether granulocytes, which contaminate PBMC isolates after prolonged blood storage at room temperature, are responsible for inhibited T cell function in aged blood. We extend previous observations by characterizing these contaminating granulocytes as CD11b+ CD15+ cells comparable to activated CD11b+ CD15+ granulocytes induced by incubation of blood with FMLP. Granulocyte contamination of PBMC was observed within 6-8 h after venipuncture and room temperature storage (2.3 fold increase), and increased 11.3-fold by 24-26 h in comparison to PBMC from fresh blood. Refrigerated 22-26 hour storage of blood exacerbated granulocyte contamination (84-fold increase). In contrast, granulocyte contamination was markedly reduced if blood was diluted in RPMI-1640 medium (3.9-fold increase) or PBS (1.8-fold increase) prior to 22-26 hour room temperature storage. Granulocyte contamination significantly correlated with reduced CD3zeta chain expression, a marker of T cell dysfunction. Correspondingly, T cell proliferation following PHA stimulation was significantly decreased in PBMC with contaminating granulocytes from aged blood (77% of control) or FMLP treated blood (44% of control). Minimizing granulocyte contamination in PBMC of aged blood by cell sorting, or by reducing granulocyte activation by diluting blood in PBS prior to storage, increased CD3zeta chain expression and increased T cell proliferation following stimulation. These data indicate that granulocytes inhibit T cell function in aged blood. Therefore, preventing granulocyte activation in blood specimens is critical to maintain optimal T cell function. This may be accomplished by limiting the time from venipuncture to PBMC isolation to <8 h and may be extended to 26 h by simply diluting blood in PBS prior to room temperature storage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041316     DOI: 10.1016/j.jim.2008.10.019

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  32 in total

1.  Validation of increased blood storage times with the T-SPOT.TB assay with T-Cell Xtend reagent in individuals with different tuberculosis risk factors.

Authors:  Shu-Hua Wang; Samuel S Stew; Joshua Cyktor; Bridget Carruthers; Joanne Turner; Blanca I Restrepo
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

2.  Development of the first reference antibody panel for qualification and validation of cytokine release assay platforms - Report of an international collaborative study.

Authors:  Sandrine Vessillier; Madeline Fort; Lynn O'Donnell; Heather Hinton; Kimberly Nadwodny; Joseph Piccotti; Peter Rigsby; Karin Staflin; Richard Stebbings; Divya Mekala; Aarron Willingham; Babette Wolf
Journal:  Cytokine X       Date:  2020-12

3.  Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.

Authors:  Anke Harenberg; Sarah Begue; Audrey Mamessier; Sophie Gimenez-Fourage; Ching Ching Seah; Ai Wei Liang; Jun Li Ng; Xue Yun Toh; Sophia Archuleta; Annelies Wilder-Smith; Lynette P Shek; Anh Wartel-Tram; Alain Bouckenooghe; Jean Lang; Denis Crevat; Catherine Caillet; Bruno Guy
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

4.  Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability.

Authors:  Barry D Hock; Karen G Taylor; Nicholas B Cross; Anthony J Kettle; Mark B Hampton; Judith L McKenzie
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

5.  Stability of T cell phenotype and functional assays following heparinized umbilical cord blood collection.

Authors:  Kristin Scheible; Shelley Secor-Socha; Terry Wightman; Hongyue Wang; Thomas J Mariani; David J Topham; Gloria Pryhuber; Sally Quataert
Journal:  Cytometry A       Date:  2012-10-01       Impact factor: 4.355

6.  Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function.

Authors:  Vivek Naranbhai; Pat Bartman; Dudu Ndlovu; Pamela Ramkalawon; Thumbi Ndung'u; Douglas Wilson; Marcus Altfeld; William H Carr
Journal:  J Immunol Methods       Date:  2011-01-19       Impact factor: 2.303

7.  Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

Authors:  Hisham Abdel-Azim; Hema Dave; Kimberly Jordan; Stephanie Rawlings-Rhea; Annie Luong; Ashley L Wilson
Journal:  Cytotherapy       Date:  2021-10-26       Impact factor: 5.414

8.  Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma.

Authors:  Kyle C McKenna; Kelly M Beatty; Richard A Bilonick; Lynn Schoenfield; Kira L Lathrop; Arun D Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-15       Impact factor: 4.799

Review 9.  Biobanking past, present and future: responsibilities and benefits.

Authors:  Yvonne G De Souza; John S Greenspan
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

Review 10.  Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.

Authors:  R Mallone; S I Mannering; B M Brooks-Worrell; I Durinovic-Belló; C M Cilio; F S Wong; N C Schloot
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.